Tag: UK

Representative actions and insurance: some looming traps for product manufacturers

Introduction As reported in our earlier blog, a compromise has recently been reached in respect of the content of a new EU Directive on consumer collective redress (the Directive), with the final directive likely to come into force by the end of the year and member states to transpose it […]

EU representative actions: do they represent a major consumer rights shakeup?

Edward Turtle and Tracey Bischofberger

We consider the implications of a new EU Directive to introduce representative actions for breaches of certain EU laws, including consumer rights, product liability and product safety legislation.

Productwise 3-2-1

Tracey Bischofberger, Matt Howsare and Claire Temple

Introducing Productwise 3-2-1, our monthly bite-sized digest of the current key issues in products law.

EU and AI – Navigating the European Approach

Fergal Duggan

Get access to Cooley’s webinar on the European Commission’s White Paper on Artificial Intelligence

Flexibility for our furry friends

Sarah-Jane Dobson and Olivia Flasch

EU regulators have taken steps to address supply chain disruption and increased demand in veterinary medicines caused by the COVID-19 pandemic.

UK-specific guidance for the application and management of clinical trials in the context of COVID-19

Sarah-Jane Dobson and Amal Ali

The UK’s MHRA has stated it will be particularly flexible and pragmatic in authorising clinical trials connected to COVID-19, referring to its previous track record of having acted swiftly in past public health crises

COVID-19: Weekly Life Sciences Digest – PPE in EU and UK

Sarah-Jane Dobson, Edward Turtle, Harriet Jones and Julia Maskell

With COVID-19 heralding unprecedented changes in the sector, our life sciences products experts provide a weekly summary of key international developments to keep you up to date.

FSA raises bar for CBD food products

Jamie Humphreys and Emma Lidstrom

UK food safety watchdog issues warning to CBD businesses that their products could be ‘taken off the shelves’ if the industry fails to submit valid novel food authorisation applications by 31 March 2021.